Prasterone Patent Expiration

Prasterone is Used for managing dyspareunia in menopausal women with vulvar and vaginal atrophy. It was first introduced by Millicent Pharma Ltd in its drug Intrarosa on Nov 16, 2016.


Prasterone Patents

Given below is the list of patents protecting Prasterone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Intrarosa US8268806 Pharmaceutical compositions Mar 19, 2031 Millicent
Intrarosa US8629129 Pharmaceutical compositions Aug 07, 2028 Millicent
Intrarosa US8957054 Pharmaceutical compositions Jan 08, 2030 Millicent


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳